Contemporary Medical Options for Treating Patients With Heart Failure

Marvin A. Konstam, Douglas L. Mann · Circulation · 2002

Summary

A 72-year-old woman presented with shortness of breath and manifested each of the 3 principal factors linked to increased risk of developing heart failure, which are hypertension, ischemic heart disease, and diabetes.

Type: article
Published: 2002-05-14
Cited by: 17
References: 29
Access: Open access
DOI: https://doi.org/10.1161/01.cir.0000017420.85607.2d
PubMed: https://pubmed.ncbi.nlm.nih.gov/12010904/
OpenAlex: https://openalex.org/W2097647606
Semantic Scholar: https://api.semanticscholar.org/CorpusID:5091301

Keywords

Medicine, Heart failure, Intensive care medicine, Cardiology, Internal medicine

References

Heart failure: evaluation and care of patients with left ventricular systolic dysfunction.正之田川 — 1995
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.Fernando Reati — 2002
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.H. J. Dargie — 2001
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)A. Hjalmarson, S. Goldstein, B. Fagerberg — 1999
The Cardiac Insufficiency Bisoprolol Study II.GA Drummond, I B Squire — 1999
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).Karl Swedberg, John Kjekshus — 1988
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.Aram V. Chobanian, George L. Bakris, Henry R. Black — 2003
The progression from hypertension to congestive heart failure.Daniel Levy — 1996
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke — 2001
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.Jay N. Cohn, Gianni Tognoni — 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw — 2001
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)Bertram Pitt, Robert Segal, Felipe A Martinez — 1997
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureJay N. Cohn, Donald Archibald, Susan Ziesche — 1986
Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995Kate Macintyre, Simon Capewell, Simon Stewart — 2000
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.Lechat, P, Brunhuber, Kw, Hofmann, R — 1999
Effect of carvedilol on survival in severe chronic heart failure.Milton Packer, Andrew J.S. Coats, Michael B. Fowler — 2001
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.Bertram Pitt, Faı̈ez Zannad, Willem J. Remme — 1999
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureBertram Pitt, Faı̈ez Zannad, Willem J. Remme — 2000
Literature alertNorman K. Hollenberg — 2002
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.The SOLVD Investigators* — 1991

Cited by

Ginseng-Aconite Decoction elicits a positive inotropic effect via the reverse mode Na+/Ca2+ exchanger in beating rabbit atria.Hao Cui, Hye Yoom Kim, Dae Gill Kang — 2013
Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure.Dov Freimark, Micha S. Feinberg, Shlomi Matezky — 2004
Diastolic heart failure: definitions and terminology.Michael R. Zile, Catalin F. Baicu, D. Dirk Bonnema — 2005
DEFECTIVE INTRACELLULAR Ca2+ HOMEOSTASIS CONTRIBUTES TO MYOCYTE DYSFUNCTION DURING VENTRICULAR REMODELLING INDUCED BY CHRONIC VOLUME OVERLOAD IN RATSYanfeng Ding, Gregory L. Brower, Qiao Zhong — 2008
Impact of congestive heart failure and other cardiac diseases on patient outcomes.Allan J. Collins — 2002
Is depressed myocyte contractility centrally involved in heart failure?Steven R. Houser, Kenneth B. Margulies — 2003
End-stage heart failure: Surgical therapy and implantable devicesMohamad El-Zaru, David De Nofrio — 2002
The positive inotropic effect of the aqueous extract of Convallaria keiskei in beating rabbit atria.Deok Ho Choi, Dae Gill Kang, Xun Cui — 2006
Do Pharmacological Differences Among Beta-Blockers Affect Their Clinical Efficacy in Heart Failure?Andrea Di Lenarda, Gastone Sabbadini, Gianfranco Sinagra — 2004
Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.Michael R. Zile, Catalin F. Baicu, William H. Gaasch — 2004
Thoracic organ transplantationRichard N. Pierson, Mark L. Barr, Keith McCullough — 2004
Ethanol Extract of Lepidium apetalum Seed Elicits Contractile Response and Attenuates Atrial Natriuretic Peptide Secretion in Beating Rabbit AtriaSeung Ju Kim, Hye Yoom Kim, Yun Jung Lee — 2013
Nosologie de l’insuffisance cardiaque diastoliquePierre Dos Santos, François Picard — 2007
Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure.Paolo Ferrari, R. Micheletti, Gabriele Valentini — 2007
Effekte von Herzinsuffizienz und Kardiomyopathie-assoziierter Mutationen des Troponin I auf die Kontraktions- und Relaxationskinetik isolierter KardiomyofibrillenMartina Krüger — 2003
EFFECTS OF GENETIC MANIPULATION OF PHOSPHOLAMBAN PROTEIN LEVELS ON CONTRACTILE FUNCTION AND REMODELING IN MURINE CARDIAC AND SLOW-TWITCH SKELETAL MUSCLESQiujing Song — 2004
Do Contractile Proteins Contribute to Depressed Contractility in Heart Failure ?2003
ACE-Inhibitors, β-Blockers, Spironolactone: Do We Need Many More Drugs to Treat Chronic Heart Failure?G. Sinagra, G. Sabbadini, A. Perkan — 2003

Contemporary Medical Options for Treating Patients With Heart Failure

Summary

Keywords

References

Cited by

Related papers